• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares (NQ:LSE)

    5.300 -0.130 (-2.39%)
    Streaming Delayed Price Updated: 12:23 PM EST, Mar 5, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 16,391
    Open 5.410
    Bid (Size) 5.300 (1,000)
    Ask (Size) 5.650 (100)
    Prev. Close 5.430
    Today's Range 5.010 - 5.740
    52wk Range 3.800 - 14.99
    Shares Outstanding 17,025,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    PPHC To Report Fourth Quarter and Full Year 2025 Financial Results on March 23, 2026
    From Public Policy Holding Company, Inc.
    Via GlobeNewswire
    News headline image
    HUTCHMED Reports 2025 Full Year Results and Business Updates
    From HUTCHMED (China) Limited
    Via GlobeNewswire

    Performance

    YTD
    +24.1%
    +24.1%
    1 Month
    +14.3%
    +14.3%
    3 Month
    +3.3%
    +3.3%
    6 Month
    -1.9%
    -1.9%
    1 Year
    N/A
    N/A

    More News

    Read More
    News headline image
    HUTCHMED Initiates Global Trial of PI3K/PIKK-EGFR ATTC Candidate HMPL-A580 in Patients with Solid Tumors
    From HUTCHMED (China) Limited
    Via GlobeNewswire
    News headline image
    Avacta's pre|CISION Mechanism for Payload Delivery Shows Key Advantages Compared to an Antibody Drug Conjugate in Innovative AI-Driven Analysis
    From Avacta Group PLC
    Via GlobeNewswire
    News headline image
    Leishen Energy Holding Co., Ltd. Announced Fiscal Year 2025 Financial Results Highlighting Strong Operating Cash Flow and Low Financial Leverage
    From Leishen Energy Holding Co., Ltd.
    Via GlobeNewswire
    News headline image
    Corero Network Security to Present at the AI & Technology Virtual Investor Conference February 19th
    From Virtual Investor Conferences
    Via GlobeNewswire
    News headline image
    Avacta appoints Francis Wilson as Chief Scientific Officer
    From Avacta Group PLC
    Via GlobeNewswire
    News headline image
    HUTCHMED to Announce 2025 Final Results
    From HUTCHMED (China) Limited
    Via GlobeNewswire
    News headline image
    HOOKIPA Pharma Announces Sale of Oncology Assets to NeoTrail Therapeutics
    From HOOKIPA Pharma Inc.
    Via GlobeNewswire
    News headline image
    Avacta Announces Two Key Clinical Updates to its Faridoxorubicin Program
    From AVACTA GROUP PLC
    Via GlobeNewswire
    News headline image
    Interim Results for the six months ended 31 October 2025
    From Scancell Holdings Plc
    Via GlobeNewswire
    News headline image
    Scancell announces FDA clearance of IND application for global Phase 3 trial of iSCIB1+ in advanced melanoma
    From Scancell Holdings Plc
    Via GlobeNewswire
    News headline image
    Leishen Energy Holding Co., Ltd. Announces Receipt of Nasdaq Notice Regarding Annual Meeting Requirement
    From Leishen Energy Holding Co., Ltd.
    Via GlobeNewswire
    News headline image
    Avacta Announces U.S. Food and Drug Administration Clearance of the Investigational New Drug (IND) Application for the Second pre|CISION® Medicine, FAP-Exatecan (AVA6103)
    From AVACTA GROUP PLC
    Via GlobeNewswire
    News headline image
    Avacta Announces Year-end Trading Update
    From AVACTA GROUP PLC
    Via GlobeNewswire
    News headline image
    HUTCHMED Highlights Publication of Phase III SACHI Results in The Lancet
    From HUTCHMED (China) Limited
    Via GlobeNewswire
    News headline image
    HUTCHMED Announces Positive Topline Results of Phase III Part of ESLIM-02 Trial of Sovleplenib for Warm Antibody Autoimmune Hemolytic Anemia in China
    From HUTCHMED (China) Limited
    Via GlobeNewswire
    News headline image
    HUTCHMED Initiates Phase III Stage of the Ongoing Trial of the Combination of Surufatinib and Camrelizumab for Treatment-Naïve Pancreatic Ductal Adenocarcinoma
    From HUTCHMED (China) Limited
    Via GlobeNewswire
    News headline image
    HUTCHMED Announces NDA Acceptance in China with Priority Review Status for Savolitinib for the treatment of Gastric Cancer Patients with MET Amplification
    From HUTCHMED (China) Limited
    Via GlobeNewswire
    News headline image
    HUTCHMED Announces NDA Acceptance in China with Priority Review Status for Fanregratinib in Second-Line Intrahepatic Cholangiocarcinoma
    From HUTCHMED (China) Limited
    Via GlobeNewswire
    News headline image
    Caledonia Mining Corporation Plc: Director/PDMR Shareholding Notification
    From Caledonia Mining Corporation Plc
    Via GlobeNewswire
    News headline image
    Caledonia Mining Corporation Plc: Zimbabwe government amends proposed changes to the royalty and tax regimes
    From Caledonia Mining Corporation Plc
    Via GlobeNewswire
    News headline image
    Faridoxorubicin (AVA6000) Phase 1b cohort demonstrates clinically meaningful tumor shrinkage in patients with salivary gland cancers
    From AVACTA GROUP PLC
    Via GlobeNewswire
    News headline image
    HUTCHMED Initiates Global Clinical Development of ATTC Candidate HMPL-A251 in Patients with Solid Tumors
    From HUTCHMED (China) Limited
    Via GlobeNewswire
    News headline image
    Caledonia Mining Corporation Plc: Utilisation of the block admission in respect of ATM Sales Agreement
    From Caledonia Mining Corporation Plc
    Via GlobeNewswire

    Frequently Asked Questions

    Is Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares publicly traded?
    Yes, Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares is publicly traded.
    What exchange does Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares trade on?
    Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares?
    The ticker symbol for Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares is LSE on the Nasdaq Stock Market
    What is the current price of Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares?
    The current price of Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares is 5.300
    When was Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares last traded?
    The last trade of Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares was at 03/05/26 12:23 PM ET
    What is the market capitalization of Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares?
    The market capitalization of Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares is 90.23M
    How many shares of Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares are outstanding?
    Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares has 90M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.